PHARMA WORLD
ActiveSummary
PHARMA WORLD has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €517k and a net result of €45k. Equity remains stable across the filed fiscal years (±1.7% per year). Its solvency ranks better than 28% of 8692 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability48▼-19
Solvency53▲+1
Growth58=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity short (current ratio 0.19 against 0.42 in 2024; short-term debt: 43.1% and cash: 2.5% of total assets), and 72.5% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Activities of head offices; management consultancy activities (NACE 70)
about 69% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
27.5%
Return on assets
2.4%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 29-12-2025, 33 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
33 d early
2024
21 d early
2023
12 d early
2022
on the day
2021
14 d early
2020
55 d early
2019
44 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close25-09-2026 today31-01-2027 deadline
History
Financials · fiscal year 2025, abbreviated schema
Equity
€517k▲ 9.5%
2024 · €472k
Total assets
€1.88M▲ 7.4%
2024 · €1.75M
Net result
€45k▼ 35.9%
2024 · €70k
Working capital
€-657k▼ 91.0%
2024 · €-344k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€154k▲ 36.9%€35k▼ 77.2%€209k▲ 498%€122k▼ 41.9%€126k▲ 3.7%
Net result€99k▲ 43.3%€15k▼ 85.2%€140k▲ 852%€70k▼ 50.1%€45k▼ 35.9%
Equity€980k▲ 11.3%€995k▲ 1.5%€1.10M▲ 10.2%€472k▼ 57.0%€517k▲ 9.5%
Total assets€1.37M▲ 6.7%€1.30M▼ 4.9%€1.49M▲ 14.5%€1.75M▲ 17.1%€1.88M▲ 7.4%
Debt€389k▼ 3.3%€308k▼ 20.9%€395k▲ 28.2%€1.27M▲ 223%€1.36M▲ 6.6%
Working capital€95k▼ 19.1%€103k▲ 8.1%€175k▲ 69.5%€-344k€-657k▼ 91.0%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 4% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.88M
Fixed assets
€1.72M ▲ 14.8%
Current assets
€152k ▼ 37.9%
Equity and liabilities €1.88M
Equity
€517k ▲ 9.5%
Debt
€1.36M ▲ 6.6%
Debt's share of the balance-sheet total falls from 73.0% to 72.5%. Equity and debt are higher.
Key figures and ratios
EBITDA
€194k▲
2024 · €161k
Cash flow
€113k▲
2024 · €109k
Current ratio
0.19▼
2024 · 0.42
Debt to equity
2.63▼
2024 · 2.70
ROE
8.7%▼
2024 · 14.8%
ROA
2.4%▼
2024 · 4.0%
Interest coverage
3.17▼
2024 · 5.20
Debt ≤ 1 year
€809k▲
2024 · €589k
Debt > 1 year
€545k▼
2024 · €686k
Income taxes
€22k▼
2024 · €27k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €18k | €18k | €31k | €39k | €68k | ▲ 72.4% |
| Other operating charges640/8 | - | €2k | €2k | €5k | €4k | ▼ 22.7% |
| Gross operating margin9900 | €174k | €55k | €243k | €166k | €198k | ▲ 19.2% |
| Operating profit (loss)9901 | €154k | €35k | €209k | €122k | €126k | ▲ 3.7% |
| Financial income75/76B | - | €532 | €6k | €6k | €2k | ▼ 69.3% |
| Recurring financial income75 | €1k | €532 | €6k | €6k | €2k | ▼ 69.3% |
| Financial charges65/66B | - | €15k | €15k | €31k | €61k | ▲ 97.8% |
| Recurring financial charges65 | €16k | €15k | €15k | €31k | €61k | ▲ 97.8% |
| Profit (loss) for the period before taxes9903 | €139k | €21k | €200k | €97k | €67k | ▼ 31.2% |
| Income taxes67/77 | €40k | €6k | €59k | €27k | €22k | ▼ 18.8% |
| Profit (loss) for the period9904 | €99k | €15k | €140k | €70k | €45k | ▼ 35.9% |
| Profit (loss) for the period to be appropriated9905 | €99k | €15k | €140k | €70k | €45k | ▼ 35.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.37M | €1.30M | €1.49M | €1.75M | €1.88M | ▲ 7.4% |
| Fixed assets21/28 | €1.08M | €1.07M | €1.12M | €1.50M | €1.72M | ▲ 14.8% |
| Tangible fixed assets22/27 | €265k | €247k | €301k | €682k | €904k | ▲ 32.6% |
| Land and buildings22 | - | €247k | €229k | €626k | €865k | ▲ 38.2% |
| Furniture and vehicles24 | - | - | €73k | €56k | €39k | ▼ 30.7% |
| Financial fixed assets28 | €818k | €820k | €820k | €820k | €820k | = |
| Current assets29/58 | €287k | €236k | €369k | €245k | €152k | ▼ 37.9% |
| Amounts receivable within one year40/41 | €15k | €41k | €87k | €212k | €103k | ▼ 51.3% |
| Trade receivables40 | - | €4k | €0 | €14k | €235 | ▼ 98.4% |
| Other amounts receivable41 | - | €37k | €87k | €198k | €103k | ▼ 47.9% |
| Cash at bank and in hand54/58 | €268k | €191k | €280k | €31k | €47k | ▲ 51.7% |
| Deferred charges and accrued income490/1 | - | €4k | €3k | €2k | €1k | ▼ 9.6% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.37M | €1.30M | €1.49M | €1.75M | €1.88M | ▲ 7.4% |
| Equity10/15 | €980k | €995k | €1.10M | €472k | €517k | ▲ 9.5% |
| Contributions10/11 | - | €596k | €596k | €19k | €19k | = |
| Reserves13 | €385k | €399k | €501k | €453k | €498k | ▲ 9.9% |
| Non-distributable reserves130/1 | - | €13k | €13k | €0 | - | - |
| Reserves not available under the articles1311 | - | €13k | €13k | €0 | - | - |
| Distributable reserves133 | - | €386k | €488k | €453k | €498k | ▲ 9.9% |
| Profit (loss) carried forward14 | - | - | €0 | €0 | €0 | - |
| Amounts payable17/49 | €389k | €308k | €395k | €1.27M | €1.36M | ▲ 6.6% |
| Amounts payable after more than one year17 | €197k | €171k | €199k | €686k | €545k | ▼ 20.4% |
| Financial debts170/4 | - | €171k | €199k | €686k | €545k | ▼ 20.4% |
| Amounts payable within one year42/48 | €191k | €132k | €194k | €589k | €809k | ▲ 37.4% |
| Current portion of amounts payable after more than one year42 | - | €26k | €43k | €134k | €140k | ▲ 4.3% |
| Financial debts43 | - | €0 | - | - | - | - |
| Credit institutions430/8 | - | €0 | - | - | - | - |
| Trade debts44 | €6k | €7k | €4k | €36k | €6k | ▼ 84.4% |
| Suppliers440/4 | - | €7k | €4k | €36k | €6k | ▼ 84.4% |
| Taxes, remuneration and social security45 | - | €9k | €66k | €55k | €42k | ▼ 24.9% |
| Taxes450/3 | - | €9k | €66k | €55k | €42k | ▼ 24.2% |
| Remuneration and social security454/9 | - | - | - | €550 | €0 | ▼ 100% |
| Other amounts payable47/48 | - | €91k | €81k | €363k | €622k | ▲ 71.3% |
| Accrued charges and deferred income492/3 | - | €5k | €1k | €816 | €5k | ▲ 511% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €99k | €15k | €140k | €70k | €45k | ▼ 35.9% |
| + Depreciation and write-downs630 | €18k | €18k | €31k | €39k | €68k | ▲ 72.4% |
| Operating cash flow (approximation) | €117k | €33k | €171k | €109k | €113k | ▲ 3.2% |
| Investment in fixed assets (approximation) | - | €-3k | €-86k | €-420k | €-290k | ▲ 30.9% |
| Change in cash | - | €-77k | €88k | €-249k | €16k | ▲ 106% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
More with these figures Sector benchmark What changed Value indication
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
29-12
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
30-06
Financial
Equity above €500kEq €517k ▲9.5%
7 profitable years in a row build equity to €517k.
10-01
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
19-01
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
30-06
Financial
Highest result since 2019net €140k ▲852%
Operating result €209k, net result €140k, both a record.
30-06
Financial
Equity above €1MEq €1.10M ▲10.2%
5 profitable years in a row build equity to €1.10M.
31-01
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-06
Financial
Weakest financial yearnet €15k ▼85.2%
Net result drops to €15k, the lowest in the series; recovery starts the following year.
17-01
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2020
07-12
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2019
18-12
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
21-12
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
26-12
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
02-01
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Nieuwpoort · 1 establishment unit since 2005
Ground area
1,014 m²
Building footprint
356 m²
Volume, LiDAR
2,927 m³
2 parcels, Flanders · tallest building 12.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
PHARMA WORLD
since 20052.147.127.464
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 38402D0188/00H000 | Flanders | 768 m² | 1 · 98 m² | 10.2 m · 2 fl. |
| 36006C0408/00H000 | Flanders | 246 m² | 1 · 258 m² | 12.3 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
INRO
BE 0863.963.360
Dilbeek · Eq €516,414
BEOPAR
BE 0789.351.455
Ukkel · Eq €516,403
GNG
BE 0885.284.653
Brasschaat · Eq €516,339
SOFIL INVEST
BE 0861.759.579
Kortrijk · Eq €516,697
Realpartners Group
BE 0885.764.408
Ukkel · Eq €516,786
Of 82,632 companies in sector 70200 we hold annual accounts for 52,575. 34,386 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded25-01-2005
Fiscal year end30-06
Activities, NACEBEL 2025
70200Business and other management consultancy
Scores and ratios are computed by Checked and are not a credit decision.